These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 163719)

  • 1. The effect of 1,25-dihydroxycholecalciferol on renal tubular reabsorption of phosphate, intestinal absorption of calcium and bone histology in hypophosphataemic renal tubular rickets.
    Russell RG; Smith R; Preston C; Walton RJ; Woods CG; Henderson RG; Norman AW
    Clin Sci Mol Med; 1975 Mar; 48(3):177-86. PubMed ID: 163719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.
    Patel L; Clayton PE; Brain C; Pelekouda E; Addison GM; Price DA; Mughal MZ
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):687-96. PubMed ID: 8759181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal hypophosphataemic bone disease responds to 1,25-(OH)2D3.
    Scriver CR; Reade T; Halal F; Costa T; Cole DE
    Arch Dis Child; 1981 Mar; 56(3):203-7. PubMed ID: 7212758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypophosphatemic vitamin D-resistant rickets: metabolic balance studies in a child receiving 1,25 dihydroxyvitamin D3, phosphate, and ascorbic acid.
    Hirschman GH; DeLuca HF; Chan JC
    Pediatrics; 1978 Mar; 61(3):451-7. PubMed ID: 25411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.
    Seino Y; Shimotsuji T; Ishii T; Ishida M; Ikehara C; Yamaoka K; Yabuuchi H; Dokoh S
    Arch Dis Child; 1980 Jan; 55(1):49-53. PubMed ID: 6246841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral 1,25 dihydroxycholecalciferol on calcium and phosphate malabsorption in primary biliary cirrhosis.
    Farrington K; Epstein O; Varghese Z; Newman SP; Moorhead JF; Sherlock S
    Gut; 1979 Jul; 20(7):616-9. PubMed ID: 488759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 1,25-dihydroxyvitamin D3 on the renal handling of Pi in thyroparathyroidectomized rats.
    Bonjour JP; Preston C; Fleisch H
    J Clin Invest; 1977 Dec; 60(6):1419-28. PubMed ID: 915006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 1,25-dihydroxyvitamin D3 on phosphate homeostasis in the X-linked hypophosphatemic (Hyp) mouse.
    Tenenhouse HS; Scriver CR
    Endocrinology; 1981 Aug; 109(2):658-60. PubMed ID: 6894727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal phosphate absorption in normal and uremic man: effects of 1,25(OH)2-vitamin D3 and 1alpha(OH)-vitamin D3.
    Coburn JW; Brickman AS; Hartenbower DL; Norman AW
    Adv Exp Med Biol; 1977; 81():549-57. PubMed ID: 899939
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological activity of 1alpha,24-dihydroxycholecalciferol; a new synthetic analog of the hormonal form of vitamin D.
    Kawashima H; Hoshina K; Hashimoto Y; Takeshita T; Ishimoto S
    FEBS Lett; 1977 Apr; 76(2):177-81. PubMed ID: 862898
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of genetically hypophosphatemic mice by 1 alpha-hydroxyvitamin D3 but not 1,25-dihydroxyvitamin D3.
    Beamer WG; Wilson MC; DeLuca HF
    Endocrinology; 1980 Jun; 106(6):1949-55. PubMed ID: 6892799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man?
    Kanis JA; Cundy T; Bartlett M; Smith R; Heynen G; Warner GT; Russell RG
    Br Med J; 1978 May; 1(6124):1382-6. PubMed ID: 647302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of hypophosphataemic vitamin D-resistant rickets treated with initial massive doses of 1 alpha-hydroxy-vitamin D3 alone.
    Muraki K; Nishi Y; Tsuda K; Yoshimitsu K; Usui T
    Acta Paediatr Scand; 1983 Sep; 72(5):763-8. PubMed ID: 6314737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tubular and intestinal phosphate transport in vitamin D-resistant (hypophosphatemic) rickets (author's transl)].
    Schabel F; Kurz R; Madreiter H; Reinken L; Zieglauer H
    Padiatr Padol; 1977; 12(2):152-7. PubMed ID: 193082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrous dysplasia of bone with vitamin D resistant rickets: a case study.
    Ryan WG; Nibbe AF; Schwartz TB; Ray RD
    Metabolism; 1968 Nov; 17(11):988-98. PubMed ID: 5724172
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
    Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
    J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
    Glorieux FH; Marie PJ; Pettifor JM; Delvin EE
    N Engl J Med; 1980 Oct; 303(18):1023-31. PubMed ID: 6252463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of rickets and osteomalacia in familial hypophosphataemia.
    Condon JR; Nassim JR; Rutter A
    Arch Dis Child; 1971 Jun; 46(247):269-72. PubMed ID: 5090660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of parathyroid hormone on cAMP and 1,25-dihydroxyvitamin D formation and renal handling of phosphate in vitamin D-dependent rickets.
    Aarskog D; Aksnes L; Markestad T
    Pediatrics; 1983 Jan; 71(1):59-63. PubMed ID: 6294581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.